Published in Br J Radiol on December 01, 2011
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55
IDH1 and IDH2 mutations in gliomas. N Engl J Med (2009) 32.41
MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med (2005) 29.65
Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer (2010) 11.16
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res (2003) 8.06
Brain tumour stem cells. Nat Rev Cancer (2006) 5.84
Neural stem cells and the origin of gliomas. N Engl J Med (2005) 5.43
Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet (2002) 5.21
Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro Oncol (1999) 4.25
Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med (2003) 3.56
Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme. J Clin Oncol (2008) 3.50
Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol (2005) 3.46
Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma. J Clin Oncol (2007) 3.29
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme. BMC Cancer (2009) 1.80
Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. J Neurosurg (2005) 1.63
Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme. Expert Opin Investig Drugs (2008) 1.56
Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors. Int J Cancer (2005) 1.48
Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg (1988) 1.40
Cancer stem cells and glioma. Nat Clin Pract Neurol (2008) 1.29
Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro. Neuro Oncol (2009) 1.15
Identification of expressed genes characterizing long-term survival in malignant glioma patients. Oncogene (2006) 1.09
Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours. Br J Radiol (2011) 1.00
Imaging biomarkers of brain tumour margin and tumour invasion. Br J Radiol (2011) 0.96
Current therapy for brain tumors: back to the future. Arch Neurol (1999) 0.92
Recurrent high-grade glioma: a diagnostic and therapeutic challenge. Expert Rev Neurother (2011) 0.88
Imaging hypoxia in gliomas. Br J Radiol (2011) 0.87
Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: analysis of the response and core pathway aberrations. Chin Med J (Engl) (2009) 0.87
Diagnosis and treatment in neuro-oncology: an oncological perspective. Br J Radiol (2011) 0.85